4//SEC Filing
Singleton Mark 4
Accession 0001062993-22-002728
CIK 0001822691other
Filed
Feb 3, 7:00 PM ET
Accepted
Feb 4, 7:28 PM ET
Size
10.2 KB
Accession
0001062993-22-002728
Insider Transaction Report
Form 4
Singleton Mark
VP of Technology
Transactions
- Award
Stock Option (Right to Buy)
2022-02-02+192,936→ 192,936 totalExercise: $1.23Exp: 2031-02-09→ Common Stock (192,936 underlying) - Award
Stock Option (Right to Buy)
2022-02-02+13,399→ 13,399 totalExercise: $1.23Exp: 2031-02-09→ Common Stock (13,399 underlying) - Award
Stock Option (Right to Buy)
2022-02-02+126,424→ 126,424 totalExercise: $2.61Exp: 2031-06-30→ Common Stock (126,424 underlying)
Footnotes (4)
- [F1]25% of the shares underlying the option vested or shall vest on February 9, 2022 and the remainder of the shares vested or shall vest in 36 equal monthly installments thereafter, starting March 9, 2022.
- [F2]This option was issued pursuant to the terms of a business combination agreement involving the Issuer and GreenLight Biosciences, Inc. in exchange for a comparable option previously issued by such company.
- [F3]25% of the shares underlying the option vested or shall vest on February 9, 2022 and the remainder of the shares vested or shall vest in 36 equal monthly installments thereafter, starting March 9, 2022.
- [F4]25% of the shares underlying the option vested or shall vest on June 30, 2022 and the remainder of the shares vested or shall vest in 36 equal monthly installments thereafter, starting July 30, 2022.
Issuer
GreenLight Biosciences Holdings, PBC
CIK 0001822691
Entity typeother
Related Parties
1- filerCIK 0001908629
Filing Metadata
- Form type
- 4
- Filed
- Feb 3, 7:00 PM ET
- Accepted
- Feb 4, 7:28 PM ET
- Size
- 10.2 KB